Pharmacology CME Review Package
- Price: $399.99
- Duration: 30 months of access
- Deliverables: 12.0 Hours of Category 1 AAPA CME
- Credit Type: AAPA Category 1 Pharmacology Credit
- Format: Online, self-paced review
PANRE Review Course
- Price: $399.99
- Duration: 30 months of access
- Deliverables: 100 Hours of Category 1 AAPA CME, 1,672 board-style questions
- Format: Comprehensive online review
The Clinical Reality of 2026
Pharmacology is the cornerstone of clinical practice. As a Physician Assistant, your ability to navigate complex medication regimens is what defines your utility in the healthcare system. In 2026, the complexity of new biologicals, second-generation SGLT2 inhibitors, and evolving antibiotic resistance patterns makes online pharmacology CME for PAs more than just a box to check for licensure: it is a necessity for patient safety.
While many states and employers are tightening requirements, the need for AAPA Category 1 pharmacology credit remains constant. You need credit that is recognized, efficient, and, most importantly, clinically relevant.
Why PA-Written Content Matters
Generic CME often fails to address the specific scope and challenges of PA practice. Our Pharmacology Course was written by physician assistants for physician assistants. We focus on high-yield clinical decision-making: which drug to choose, why it is preferred over the alternatives, and how to manage the most common side effects seen in a busy clinic or hospital setting.
For those preparing for the PANRE or PANRE-LA, pharmacology makes up a significant portion of the NCCPA Blueprint. Mastering these concepts early in your 10-year cycle or during your recertification window is the most strategic way to ensure a passing score.
Maximizing Your CME Budget with Gift Cards
We recognize that PAs are often looking for the most efficient way to utilize their employer-provided CME funds. To facilitate further educational enrichment, we offer CME packages with Amazon and Apple Gift Card add-ons.
Purchasers can select a package that includes a $100 to $1,500 Gift Card. This allows you to purchase the medical equipment, textbooks, or technology you need to advance your practice, all within a single CME transaction. This is a pragmatic solution for PAs, NPs, and physicians who want to maximize the value of their professional development budget.
Clinical Assessment: Cardiovascular Pharmacology
Your patient is a 64-year-old male with a history of hypertension, Type 2 Diabetes, and Stage 3 Chronic Kidney Disease (CKD). His current medications include Metformin and Lisinopril. At today’s visit, his blood pressure is 152/94 mmHg (HR 72, SaO2 98%). Laboratory results show a potassium level of 5.2 mEq/L and an escalating serum creatinine. You decide to add a second agent for blood pressure control.
Which of the following is the most appropriate next step in pharmacological management?
A) Increase Lisinopril to maximum dose
B) Add Spironolactone
C) Add Amlodipine
D) Add Chlorthalidone
Correct Answer: C) Add Amlodipine.
Calcium channel blockers (CCBs) like Amlodipine are effective and generally safe in patients with advanced CKD and hyperkalemia. Increasing the ACE inhibitor (Lisinopril) or adding a potassium-sparing diuretic like Spironolactone would significantly increase the risk of worsening hyperkalemia (K+ > 5.5). While Chlorthalidone is a potent diuretic, thiazide-type diuretics lose efficacy as the GFR drops below 30 ml/min. CCBs provide potent BP lowering without the metabolic risks associated with the other options in this specific clinical context.
Clinical Assessment: Endocrine Pharmacology
Your patient is a 45-year-old female with newly diagnosed Type 2 Diabetes. Her BMI is 34 kg/m². Her A1c is 8.1%. She has no history of heart failure or CKD. She expresses significant concern regarding weight gain, as she has struggled with obesity for several years. She is currently taking no medications.
Which of the following medications offers the most significant benefit for both glycemic control and weight loss?
A) Glipizide
B) Pioglitazone
C) Semaglutide
D) Insulin Glargine
Correct Answer: C) Semaglutide.
Semaglutide (a GLP-1 receptor agonist) is the correct choice because it provides superior A1c reduction while promoting significant weight loss. In contrast, Sulfonylureas (Glipizide), TZDs (Pioglitazone), and Insulin are all associated with weight gain. In a patient where weight management is a primary goal alongside glycemic control, GLP-1 agonists or SGLT2 inhibitors are the preferred second-line agents after or alongside Metformin.
Clinical Assessment: Infectious Disease Pharmacology
Your patient is a 28-year-old female presenting with frequency, urgency, and suprapubic pain for two days. She denies fever, chills, or flank pain. She has no significant past medical history and no known drug allergies. A point-of-care urinalysis is positive for nitrites and leukocyte esterase. You diagnose an uncomplicated urinary tract infection (UTI).
Which of the following is considered first-line therapy for this patient according to current IDSA guidelines?
A) Ciprofloxacin
B) Nitrofurantoin
C) Cephalexin
D) Doxycycline
Correct Answer: B) Nitrofurantoin.
Nitrofurantoin (Macrobid) is a first-line agent for uncomplicated cystitis due to its high efficacy against common uropathogens and low rate of resistance. Fluoroquinolones like Ciprofloxacin should be reserved for more complicated infections or when first-line agents cannot be used, due to the risk of significant side effects (tendon rupture, C. diff). Cephalexin is an alternative but not preferred over Nitrofurantoin or TMP-SMX. Doxycycline is not a first-line treatment for UTI.
The Value for Nurse Practitioners and Physicians
While our content is designed by PAs, it holds significant value for the entire clinical team.
- Nurse Practitioners: In many states, AAPA Category 1 Credit is accepted for NP recertification and licensure requirements. It is essential to check your specific state board regulations.
- Physicians: While this content counts as Category 2 CME for physicians rather than Category 1, many Internal Medicine and Hospitalist physicians purchase our CME packages for the high-yield clinical updates and the gift card add-on options.
Final Thoughts on Pharmacology CME
In 2026, staying current isn't just about meeting a requirement; it's about maintaining the clinical edge required to provide high-quality care. Whether you are looking for 100 hours of AAPA Category 1 credit to knock out your entire cycle or a targeted 12-hour pharmacology update, our courses provide the most efficient path forward.
By choosing a course with an Amazon or Apple Gift Card, you turn your required professional development into a tool for further enrichment.
